Results 111 to 120 of about 978,166 (202)

Diagnostic Evaluation of Cutaneous Mastocytosis with Atypical Urinary Manifestations: A Case Report

International Journal of Medical Students
Background This case study involves the progression of a diagnosed incidence of cutaneous mastocytosis from birth to 9 months. Cutaneous mastocytosis is a rare condition, seen in all ages, presenting with progressive inflammatory dermatologic ...
Milin Kurup
doaj  

More Than Just a Gut Feeling: Unmasking Systemic Mastocytosis Behind Chronic Gastrointestinal Symptoms in a 2-Patient Case Series. [PDF]

ACG Case Rep J
Ramirez G, Khoudari A, Gonzalez Y, Davis-Yadley AH.   +3 more
europepmc   +1 more source

Systemic Mastocytosis: Molecular Pathophysiology, WHO Diagnostic Framework, and <i>KIT</i>-Directed Targeted Therapies. [PDF]

Cancers (Basel)
Alati C, Greve MB, Porto G, Policastro G, Bilardi E, Utano G, Giordano L, Pitea M, Martino M.   +8 more
europepmc   +1 more source

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]

Cureus
Minbaeva S, Tyring SK.
europepmc   +1 more source

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study. [PDF]

J Hematol Oncol
Hermine O, Debeaupuis O, Damaj G, Lübke J, Schwaab J, Heizmann M, Siebenhaar F, Pyatilova P, Nojarov N, Niedoszytko M, Gorska A, Mattsson M, Shoumariyeh K, de Bra S, Wortmann F, von Bubnoff N, Bumbea H, Soare D, Elena C, Várkonyi J, Fortina AB, Erdem S, Brockow K, Franz TM, Panse J, Christen D, Breynaert C, Yavuz AS, Malcovati L, Doubek M, Sabato V, Tanasi I, Bonifacio M, Hartmann K, Rüfer A, Sciumè M, Bellani V, Angelova-Fischer I, Stefan A, Triggiani M, Parente R, Klein SK, Makris M, Papageorgiou S, van Daele P, Dybedal I, Baffoe D, Gülen T, Jentzsch M, Lortholary O, Heiblig M, Livideanu CB, Barete S, Gourguechon C, Dimicoli-Salazar S, Tournilhac O, Frenzel L, Arock M, Mital A, Woltsche JN, Kluin-Nelemans HC, Elberink JNGO, Gotlib J, Sperr M, Reiter A, Valent P, Sperr WR, Rossignol J.   +67 more
europepmc   +1 more source

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study. [PDF]

Blood Adv
Gotlib J, Reiter A, Radia DH, Álvarez-Twose I, Deininger MW, George TI, Panse J, Mital A, Pettit KM, Vannucchi AM, Platzbecker U, Hermine O, Elshoury A, Livideanu CB, Mesa R, Ustun C, Triggiani M, Dybedal I, Jurcic JG, Zanotti R, Oh ST, Yacoub A, Hexner EO, Bose P, Lee SG, Sperr WR, Griffiths EA, Butler M, Lübke J, Bidollari I, Lin HM, Rylova S, Dimitrijević S, Muñoz-González JI, DeAngelo DJ.   +34 more
europepmc   +1 more source

Diagnosing Systemic Mastocytosis: State of the Art. [PDF]

Int J Lab Hematol
Rets A, George TI.
europepmc   +1 more source

Refractory cutaneous symptoms in systemic mastocytosis. [PDF]

JAAD Case Rep
Gleason L, Bhatti SA, Wallace M, Lee JB, Alpdogan O, Nikbakht N.   +5 more
europepmc   +1 more source

Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM). [PDF]

Qual Life Res
Marcus JC, Akin C, Zhang J, Easton R, Lim-Watson M, Siebenhaar F, Gwaltney C, Turner R.   +7 more
europepmc   +1 more source

Hidden in Plain Sight: Systemic Mastocytosis Manifesting as Isolated Hepatosplenomegaly in the Absence of Cutaneous and Classical Manifestations-A Case Report and Literature Review. [PDF]

Clin Case Rep
Sadam Zeb M, Mian UU, Khan K, Gulalay A, Hameed A, Malook A, Saeed E, Khan S, Mujtaba M, Kamil KA.   +9 more
europepmc   +1 more source